Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
21.45 USD | +9.38% | +4.13% | +680.00% |
Apr. 30 | Health Care Flat Amid Mixed Earnings -- Health Care Roundup | DJ |
Apr. 30 | Sector Update: Health Care Stocks Mixed Late Afternoon | MT |
Financials (USD)
Sales 2024 * | 243M | Sales 2025 * | 274M | Capitalization | 561M |
---|---|---|---|---|---|
Net income 2024 * | -77M | Net income 2025 * | -46M | EV / Sales 2024 * | 2.31 x |
Net cash position 2024 * | - | Net cash position 2025 * | - | EV / Sales 2025 * | 2.05 x |
P/E ratio 2024 * |
-7.47
x | P/E ratio 2025 * |
-13.7
x | Employees | 1,000 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 68.69% |
Latest transcript on GeneDx Holdings Corp.
1 day | +9.38% | ||
1 week | +4.13% | ||
Current month | +9.38% | ||
1 month | +9.10% | ||
3 months | +151.76% | ||
6 months | +1,091.67% | ||
Current year | +680.00% |
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 48 | 22-04-28 | |
Kevin Feeley
DFI | Director of Finance/CFO | 43 | - |
Paul Kruszka
CTO | Chief Tech/Sci/R&D Officer | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Joshua Ruch
BRD | Director/Board Member | 74 | 21-07-21 |
Director/Board Member | 68 | 22-04-30 | |
Keith Meister
BRD | Director/Board Member | 51 | 20-12-31 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.00% | 9 M€ | -.--% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-06-03 | 21.45 | +9.38% | 392,706 |
24-05-31 | 19.61 | -3.83% | 323,885 |
24-05-30 | 20.39 | -3.59% | 256,811 |
24-05-29 | 21.15 | +3.02% | 426,463 |
Delayed Quote Nasdaq, June 03, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+680.00% | 561M | |
-25.06% | 7.76B | |
+69.31% | 4.35B | |
-3.50% | 2.64B | |
+0.12% | 2.67B | |
-47.63% | 2.1B | |
-16.44% | 1.73B | |
-19.40% | 1.52B | |
+14.52% | 1.18B | |
-45.53% | 1.11B |
- Stock Market
- Equities
- WGS Stock